MAIA Biotechnology, Inc.
MAIAAMEXHealthcare● Active
$1.30
+$0.03(+2.36%)
Market Cap$79040985
P/E Ratio—
52W High$3.19
52W Low$0.87
MAIA Biotechnology, Inc. (MAIA) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
MAIA · earnings · updated Jun 9, 2026
Latest Earnings
Q2 FY2026Report Date: May 11, 2026EPS Actual
-$0.14
Est. -$0.18 · +22.2%
Revenue
—
Fiscal Period
Q2 FY2026
FY ends December
Report Date
May 11, 2026
After Market Close
▲ Beat EPS✓ 2-Quarter EPS Beat Streak
MAIA reports quarterly as a AMEX-listed Biotechnology company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
84
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
—
Days Away84
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.—
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q3 FY2026 | Aug 10, 2026 | -$0.11 | — | — | — | — | — |
| ▲ Q2 FY2026 | May 11, 2026 | -$0.18 | -$0.14 | +22.2% | — | — | — |
| ▲ Q1 FY2026 | Mar 23, 2026 | -$0.13 | -$0.08 | +38.5% | — | — | — |
| ▼ Q4 FY2025 | Nov 7, 2025 | -$0.19 | -$0.27 | -42.1% | — | — | — |
| ▲ Q3 FY2025 | Aug 11, 2025 | -$0.24 | -$0.18 | +25.0% | — | — | — |
| ▲ Q2 FY2025 | May 9, 2025 | -$0.18 | -$0.16 | +11.1% | — | — | — |
| ▲ Q1 FY2025 | Mar 21, 2025 | -$0.20 | -$0.17 | +15.0% | — | — | — |
| ▲ Q4 FY2024 | Nov 12, 2024 | -$0.32 | -$0.11 | +65.6% | — | — | — |
Q3 FY2026
Aug 10, 2026
EPS Actual
—
EPS Est.
-$0.11
EPS Surpr.
—
Revenue
—
Q2 FY2026
May 11, 2026Beat
EPS Actual
-$0.14
EPS Est.
-$0.18
EPS Surpr.
+22.2%
Revenue
—
Q1 FY2026
Mar 23, 2026Beat
EPS Actual
-$0.08
EPS Est.
-$0.13
EPS Surpr.
+38.5%
Revenue
—
Q4 FY2025
Nov 7, 2025Miss
EPS Actual
-$0.27
EPS Est.
-$0.19
EPS Surpr.
-42.1%
Revenue
—
Q3 FY2025
Aug 11, 2025Beat
EPS Actual
-$0.18
EPS Est.
-$0.24
EPS Surpr.
+25.0%
Revenue
—
Q2 FY2025
May 9, 2025Beat
EPS Actual
-$0.16
EPS Est.
-$0.18
EPS Surpr.
+11.1%
Revenue
—
Q1 FY2025
Mar 21, 2025Beat
EPS Actual
-$0.17
EPS Est.
-$0.20
EPS Surpr.
+15.0%
Revenue
—
Q4 FY2024
Nov 12, 2024Beat
EPS Actual
-$0.11
EPS Est.
-$0.32
EPS Surpr.
+65.6%
Revenue
—
Analyst Estimates
Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2027 | $-0.07 | $-0.07 | $-0.07 | 1 |
| Q3 FY2027 | $-0.11 | $-0.11 | $-0.11 | 1 |
| Q2 FY2027 | $-0.14 | $-0.14 | $-0.14 | 1 |
| Q1 FY2027 | $-0.14 | $-0.14 | $-0.14 | 1 |
| Q4 FY2026 | $-0.13 | $-0.13 | $-0.13 | 1 |
| Q3 FY2026 | $-0.12 | $-0.12 | $-0.12 | 1 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2027 | $0.0B | $0.0B | $0.0B | 0 |
| Q3 FY2027 | $0.0B | $0.0B | $0.0B | 0 |
| Q2 FY2027 | $0.0B | $0.0B | $0.0B | 0 |
| Q1 FY2027 | $0.0B | $0.0B | $0.0B | 0 |
| Q4 FY2026 | $0.0B | $0.0B | $0.0B | 0 |
| Q3 FY2026 | $0.0B | $0.0B | $0.0B | 0 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▲ Q2 FY2026 | May 11, 2026 | +22.2% | $1.32 | $1.31 | -0.76% |
| ▲ Q1 FY2026 | Mar 23, 2026 | +38.5% | $1.46 | $1.49 | +2.05% |
| ▼ Q4 FY2025 | Nov 7, 2025 | -42.1% | $1.10 | $1.12 | +1.82% |
| ▲ Q3 FY2025 | Aug 11, 2025 | +25.0% | $1.52 | $1.49 | -1.97% |
| ▲ Q2 FY2025 | May 9, 2025 | +11.1% | $1.96 | $2.04 | +4.08% |
| ▲ Q1 FY2025 | Mar 21, 2025 | +15.0% | $1.76 | $1.76 | +0.00% |
| ▲ Q4 FY2024 | Nov 12, 2024 | +65.6% | $2.63 | $2.62 | -0.38% |
| ▲ Q3 FY2024 | Aug 9, 2024 | +48.5% | $2.66 | $2.66 | +0.00% |
Q2 FY2026-0.76%
Report Date
May 11, 2026
EPS Beat/Miss
+22.2%
Price Before
$1.32
Price After
$1.31
Q1 FY2026+2.05%
Report Date
Mar 23, 2026
EPS Beat/Miss
+38.5%
Price Before
$1.46
Price After
$1.49
Q4 FY2025+1.82%
Report Date
Nov 7, 2025
EPS Beat/Miss
-42.1%
Price Before
$1.10
Price After
$1.12
Q3 FY2025-1.97%
Report Date
Aug 11, 2025
EPS Beat/Miss
+25.0%
Price Before
$1.52
Price After
$1.49
Q2 FY2025+4.08%
Report Date
May 9, 2025
EPS Beat/Miss
+11.1%
Price Before
$1.96
Price After
$2.04
Q1 FY2025+0.00%
Report Date
Mar 21, 2025
EPS Beat/Miss
+15.0%
Price Before
$1.76
Price After
$1.76
Q4 FY2024-0.38%
Report Date
Nov 12, 2024
EPS Beat/Miss
+65.6%
Price Before
$2.63
Price After
$2.62
Q3 FY2024+0.00%
Report Date
Aug 9, 2024
EPS Beat/Miss
+48.5%
Price Before
$2.66
Price After
$2.66
Avg Beat Reaction+0.43%
Avg Miss Reaction+1.82%
Beat Rate7 / 8 quarters
Largest Move+4.08% (Q2 FY2025)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: MAIA ends December
MAIA Biotechnology, Inc. (MAIA) most recently reported earnings on May 11, 2026 for Q2 FY2026, posting EPS of $-0.14 — beating the analyst consensus of $-0.18 by +22.2%. MAIA has beaten EPS estimates for 2 consecutive quarters. The next MAIA earnings date is expected around September 1, 2026.
Each quarter, investors track MAIA earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. MAIA revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
MAIA's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
MAIA earnings · 5 questionsMAIA Biotechnology, Inc.'s next earnings report is expected around September 1, 2026. MAIA typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; MAIA historically reports after market close (AMC).
MAIA earnings datewhen is MAIA earningsMAIA next earnings datewhen does MAIA report earningsMAIA earnings calendar
▸ Source: FMP · MAIA Biotechnology, Inc. SEC filings · US GAAP · MAIA Biotechnology, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026